Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an update.
ResMed Inc. has filed a notice for the proposed sale of securities under Rule 144, indicating that Michael J. Rider, an officer of the company, plans to sell 64 shares of common stock. The sale is part of a restricted stock vesting transaction, with the shares acquired as compensation. This filing suggests ongoing insider transactions, which may influence investor perceptions of the company’s stock value and market performance.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep disorders, such as sleep apnea, and other respiratory conditions. The company is known for its innovative solutions in sleep and respiratory care, aiming to improve the quality of life for patients worldwide.
YTD Price Performance: 1.17%
Average Trading Volume: 1,026,255
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.08B
For an in-depth examination of RMD stock, go to TipRanks’ Stock Analysis page.